SEC Form D · filed October 2, 2015
Antegrin Therapeutics, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (20)
Michael W. Yeadon · St. Louis, MODirectorCharles A. Bolten · St. Louis, MODirectorRobert W. Karr · St. Louis, MOExec · DirectorDavid W. Griggs · St. Louis, MODirectorGeorge H. Capps, Ii · St. Louis, MOExecRajesh J. Devraj · St. Louis, MODirectorThomas P. Cirrito · St. Louis, MODirectorMichael J. Taylor · Solon, OHDirectorScott D. Macdonald · Toronto, Ontario, CanadaDirectorJonathan Rigby · San Ramon, CADirectorPaul Wozniak · San Francisco, CAExecBrian J. Maher · Vancouver, British Columbia, CanadaDirectorWilliam C. Perkins · Madison, WIExec · DirectorElizabeth W. Cermak · San Ramon, CADirectorJames C. Stretz · Denver, COExecJorge D. Benavides Alfaro · Vancouver, British Columbia, CanadaExec · DirectorJames L. Logue, Iii · Lansing, MIDirectorBrian D. Imrie · Vancouver, British Columbia, CanadaDirectorDonald W. Huffman · San Ramon, CADirectorDiego D. De La Torre De La Piedra · Vancouver, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗